CaliPharms Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2013	FY 2012	FY 2012	FY 2011	FY 2010
Period Ending	Sep '14 Sep 30, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012	Jun '12 Jun 30, 2012	Jun '11 Jun 30, 2011	Jun '10 Jun 30, 2010
Net Income	-6.31	-0.22	-0.92	-1.03	-1.57	-5.96
Other Amortization	2.44	-	-	-	-	0.76
Asset Writedown & Restructuring Costs	0.38	-	-	-	-	-
Stock-Based Compensation	0.07	0.25	0.51	0.3	0.78	0.21
Other Operating Activities	2.76	-	-	-	-	4.27
Change in Accounts Payable	-0.09	-0.08	0.41	0.5	0.8	0.35
Change in Other Net Operating Assets	0.03	-	-	-	-0.15	0.34
Operating Cash Flow	-0.72	-0.05	-0	-0.21	-0.14	-0.59
Cash Acquisitions	-	-	-	-	0	-
Other Investing Activities	-0.04	-	-	-	-	-
Investing Cash Flow	-0.04	-	-	-	0	-
Short-Term Debt Issued	-	0.05	-	0.21	0.19	0.58
Total Debt Issued	0.78	0.05	-	0.21	0.19	0.58
Short-Term Debt Repaid	-	-	-	-	-0.05	-
Total Debt Repaid	-	-	-	-	-0.05	-
Net Debt Issued (Repaid)	0.78	0.05	-	0.21	0.14	0.58
Other Financing Activities	-	-	-	-	-	0.01
Financing Cash Flow	0.78	0.05	-	0.21	0.14	0.59
Net Cash Flow	0.02	-	-0	-0	0	-
Free Cash Flow	-0.72	-0.05	-0	-0.21	-0.14	-0.59
Free Cash Flow Margin	-641.48%	-	-	-	-	-
Free Cash Flow Per Share	-	-0.00	-	-0.05	-0.04	-0.36
Levered Free Cash Flow	-	-	-	-	2.36	5.8
Unlevered Free Cash Flow	-	-	-	-	2.57	5.59
Change in Working Capital	-0.06	-0.08	0.41	0.5	0.65	0.69

Source: S&P Global Market Intelligence. Standard template. Financial Sources.